Research Paper Volume 14, Issue 3 pp 1529—1548

Construction and validation of a prognostic risk model of angiogenesis factors in skin cutaneous melanoma


Figure 6. The prognostic performance of the AF signature risk score in the validation set. (A) The distribution of high-risk and low-risk patients based on the risk score ranking. (B) The survival duration and status of the patients. The horizontal axis is the sample, and the vertical axis is the survival time. (C) Heatmap of significant survival-related DE-AFs between high-risk and low-risk patients. (D) Kaplan–Meier survival curves of overall survival of the high- and low-risk groups stratified by the risk score calculated by the 11-AF signature risk prediction formula.